Pharmesis International Ltd. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2019. For the second quarter, the company announced revenue was CNY 10.406 million compared to CNY 19.261 million a year ago. Loss from operations was CNY 1.904 million compared to income from operating of CNY 789,000 a year ago. Loss for the period was CNY 2.190 million compared to profit of CNY 595,000 a year ago. Loss per ordinary share was 9.6 cents against 0.3 cents reported last year. For the half year, revenue was CNY 18.444 million compared to CNY 34.656 million a year ago. Loss from operations was CNY 5.309 million compared to income from operations of CNY 2.010 million a year ago. Loss for the period was CNY 5.762 million compared to profit of CNY 1.646 million a year ago. Loss per ordinary share was 21.4 cents against earnings per share of 0.8 cents reported last year.